Impact of atrial fibrillation diagnosis or carotid enderterectomy requirement on outcome in patients from the triple antiplatelets for reducing dependency after ischaemic stroke (TARDIS) trial

QR Code

Impact of atrial fibrillation diagnosis or carotid enderterectomy requirement on outcome in patients from the triple antiplatelets for reducing dependency after ischaemic stroke (TARDIS) trial

Bibliographic Details
Main Authors:	Woodhouse, Lisa J., Appleton, Jason P., Flaherty, Katie, Dineen, Robert A., Sprigg, Nikola, Bath, Philip M.
Format:	Conference or Workshop Item
Published:	2018
Online Access:	https://eprints.nottingham.ac.uk/50767/

Similar Items

Characteristics and outcomes of patients with or without a bleeding event: results from the triple antiplatelets for reducing dependency in ischaemic stroke (TARDIS) trial
by: Woodhouse, Lisa J., et al.
Published: (2018)

Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2015)

Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2017)

Prediction of major bleeding with a S2TOP-BLEED score in acute ischaemic stroke or TIA patients: a sub-study of the TARDIS trial
by: Woodhouse, Lisa J., et al.
Published: (2018)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
by: Beridze, M., et al.
Published: (2015)

Baseline predictors of on-treatment platelet activity (as P-selectin expression) in patients in the triple aniplatelets for reducing dependency in ischaemic stroke (TARDIS) trial
by: Bath, Philip M., et al.
Published: (2018)

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018)

Carotid Intima-Media Thickness and Carotid Distensibility are Associated with Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Chen, L., et al.
Published: (2012)

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)

Antiplatelet therapy following ischaemic stroke: continue or change pre-existing therapy?
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

Platelet and haemoglobin levels in patients on isosorbide mononitrate and/or cilostazol with lacunar ischaemic stroke: data from the LACI-1 trial
by: Appleton, Jason P., et al.
Published: (2018)

Peripheral and central haemodynamics in patients on isosorbide mononitrate and/or cilostazol with lacunar ischaemic stroke: data from the LACI-1 trial
by: Appleton, Jason P., et al.
Published: (2018)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

The effect of transdermal glyceryl trinitrate in acute stroke patients with carotid stenosis: data from the Efficacy of Nitric Oxide in Stroke trial
by: Appleton, J.P., et al.
Published: (2018)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

Serum amyloid protein is associated with outcome following acute ischaemic stroke: data from the REmote ischaemic Conditioning After Stroke Trial (RECAST)
by: Appleton, Jason P., et al.
Published: (2018)

A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
by: Sprigg, Nikola, et al.
Published: (2008)

Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

Remote assessment of platelet function in patients with acute stroke or transient ischaemic attack
by: Bath, Philip M.W., et al.
Published: (2017)

Antiplatelet therapy for secondary prevention in patients with ischaemic stroke and transient ischaemic attack: a retrospective cohort study in Malaysia
by: Ab Rahman N,, et al.
Published: (2023)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)

Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)

Cerebral misery perfusion due to carotid occlusive disease
by: Maddula, Mohana, et al.
Published: (2017)

Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

Antiplatelet activity should be measured routinely: no
by: Bath, Philip M.W.
Published: (2009)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)

Results from the tranexamic acid for primary intracerebral haemorrhage-2 (TICH-2) trial
by: Sprigg, Nikola, et al.
Published: (2018)